Dopamine-induced exocytosis of Na, K-ATPase is dependent on activation of protein kinase C-ε and-δ
Molecular biology of the cell, 2002•Am Soc Cell Biol
The purpose of this study was to define mechanisms by which dopamine (DA) regulates the
Na, K-ATPase in alveolar epithelial type 2 (AT2) cells. The Na, K-ATPase activity increased
by twofold in cells incubated with either 1 μM DA or a dopaminergic D1agonist, fenoldopam,
but not with the dopaminergic D2agonist quinpirole. The increase in activity paralleled an
increase in Na, K-ATPase α1 and β1 protein abundance in the basolateral membrane (BLM)
of AT2 cells. This increase in protein abundance was mediated by the exocytosis of Na, K …
Na, K-ATPase in alveolar epithelial type 2 (AT2) cells. The Na, K-ATPase activity increased
by twofold in cells incubated with either 1 μM DA or a dopaminergic D1agonist, fenoldopam,
but not with the dopaminergic D2agonist quinpirole. The increase in activity paralleled an
increase in Na, K-ATPase α1 and β1 protein abundance in the basolateral membrane (BLM)
of AT2 cells. This increase in protein abundance was mediated by the exocytosis of Na, K …
The purpose of this study was to define mechanisms by which dopamine (DA) regulates the Na,K-ATPase in alveolar epithelial type 2 (AT2) cells. The Na,K-ATPase activity increased by twofold in cells incubated with either 1 μM DA or a dopaminergic D1agonist, fenoldopam, but not with the dopaminergic D2agonist quinpirole. The increase in activity paralleled an increase in Na,K-ATPase α1 and β1 protein abundance in the basolateral membrane (BLM) of AT2 cells. This increase in protein abundance was mediated by the exocytosis of Na,K-pumps from late endosomal compartments into the BLM. Down-regulation of diacylglycerol-sensitive types of protein kinase C (PKC) by pretreatment with phorbol 12-myristate 13-acetate or inhibition with bisindolylmaleimide prevented the DA-mediated increase in Na,K-ATPase activity and exocytosis of Na,K-pumps to the BLM. Preincubation of AT2 cells with either 2-[1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl]-3-(1H-indol-3-yl)maleimide (Gö6983), a selective inhibitor of PKC-δ, or isozyme-specific inhibitor peptides for PKC-δ or PKC-ε inhibited the DA-mediated increase in Na,K-ATPase. PKC-δ and PKC-ε, but not PKC-α or -β, translocated from the cytosol to the membrane fraction after exposure to DA. PKC-δ– and PKC-ε–specific peptide agonists increased Na,K-ATPase protein abundance in the BLM. Accordingly, dopamine increased Na,K-ATPase activity in alveolar epithelial cells through the exocytosis of Na,K-pumps from late endosomes into the basolateral membrane in a mechanism-dependent activation of the novel protein kinase C isozymes PKC-δ and PKC-ε.
Am Soc Cell Biol